DarioHealth Corp (NASDAQ:DRIO) shares shot up 1.9% during trading on Wednesday . The stock traded as high as $11.25 and last traded at $7.61, 8,812 shares were traded during mid-day trading. A decline of 48% from the average session volume of 16,789 shares. The stock had previously closed at $7.47.
A number of brokerages recently commented on DRIO. Craig Hallum decreased their target price on DarioHealth from $20.00 to $12.00 and set a “buy” rating for the company in a research report on Wednesday. ValuEngine raised DarioHealth from a “buy” rating to a “strong-buy” rating in a research note on Tuesday.
The business has a fifty day moving average of $1.47 and a 200-day moving average of $0.71. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.70 and a quick ratio of 1.35.
DarioHealth (NASDAQ:DRIO) last issued its quarterly earnings data on Monday, October 28th. The company reported ($0.06) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.03. The firm had revenue of $1.87 million during the quarter. DarioHealth had a negative return on equity of 325.50% and a negative net margin of 248.57%.
A hedge fund recently bought a new stake in DarioHealth stock. Verition Fund Management LLC acquired a new position in DarioHealth Corp (NASDAQ:DRIO) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 308,334 shares of the company’s stock, valued at approximately $143,000. Verition Fund Management LLC owned 0.71% of DarioHealth as of its most recent filing with the Securities & Exchange Commission.
DarioHealth Company Profile (NASDAQ:DRIO)
DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device.
Recommended Story: Why are trading ranges significant?
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.